2Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J].Hepatology,1996,51(2):428.
3Clewell JD,Walker RP.Prostaglandins for the treatment of hepatorenal syndrome[J].Ann Pharm Acother,1994,28(1):54.
6Boyer TD, Sanyal A J, Gareia-Tsao G,et al. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1 [J]. Liver Transpl,2011,17 ( 11 ) : 1328-1332.
7Dotegowska B, Piku|a E, Safranow K, et al. Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion:the effect of alprostadil[J]. Prostaglandins Leukot Essent Fatty Acids,2006, 75(6) :403-411.
8Hossain MA, Hamamoto I, Kobayashi S, et al. The effects of intraportal administration of prostaglandin E1 on liver ischemia and hepatectomy in rats[J]. J Hepatobiliary Pancreat Surg, 1998,5 (4) :437-444.
